Kristian Heldal

Kristian Heldal is a Professor in the Department of Health Management and Health Economics at the University of Oslo. His academic focus centers on kidney transplantation outcomes, systemic inflammation, and healthcare economics, particularly in elderly patient populations. He leads research on post-transplantation immune responses, long-term graft survival, and the impact of comorbidities on transplant success.

His work integrates clinical data with economic analyses, evaluating cost-effectiveness of kidney transplantation for older patients. Key research areas include inflammation biomarkers predicting graft loss, SARS-CoV-2 vaccine efficacy in transplant recipients, and the role of klotho/fibroblast growth factor 23 in post-transplant survival.

Publications highlight collaborations with institutions like the Oslo University Hospital and international journals such as Frontiers in Immunology and Transplantation Direct. No specific awards are listed, but his contributions emphasize translational research bridging immunology, nephrology, and healthcare policy.